A recent article from MSF Access has highlighted the challegnes of implementing viral load testing in resource poor settings. We all know the benefits of viral load testing and that for diagnosing treatment failure it is the gold standard. The article highlights many of the challenges of implementing viral load testing and also potential recommendations for phased-in scale up.
What experiences have others had with viral load testing in settings where infrastructure is poor? What experiences have providers on GHD online had with using non-molecular platforms such as cavidi?